Related references
Note: Only part of the references are listed.Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides
Michael E. Ostergaard et al.
NUCLEIC ACIDS RESEARCH (2020)
Golgi-endosome transport mediated by M6PR facilitates release of antisense oligonucleotides from endosomes
Xue-hai Liang et al.
NUCLEIC ACIDS RESEARCH (2020)
RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
Sarah Bajan et al.
CELLS (2020)
Origins of the Increased Affinity of Phosphorothioate-Modified Therapeutic Nucleic Acids for Proteins
Malwina Hyjek-Skladanowska et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Interaction of ASOs with PC4 Is Highly Influenced by the Cellular Environment and ASO Chemistry
Timothy A. Vickers et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Therapeutic Antisense Oligonucleotides Are Coming of Age
C. Frank Bennett
ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
Wen Shen et al.
NATURE BIOTECHNOLOGY (2019)
Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins
Michael T. Migawa et al.
NUCLEIC ACIDS RESEARCH (2019)
Molecular anatomy of the architectural NEAT1 noncoding RNA: The domains, interactors, and biogenesis pathway required to build phase-separated nuclear paraspeckles
Tetsuro Hirose et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2019)
Current Development of siRNA Bioconjugates: From Research to the Clinic
Ivan Chernikov et al.
FRONTIERS IN PHARMACOLOGY (2019)
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2019)
Lipid Conjugates Enhance Endosomal Release of Antisense Oligonucleotides Into Cells
Shiyu Wang et al.
NUCLEIC ACID THERAPEUTICS (2019)
Phosphorothioate Antisense Oligonucleotides Bind P-Body Proteins and Mediate P-Body Assembly
Ying Wang et al.
NUCLEIC ACID THERAPEUTICS (2019)
Kinetic and subcellular analysis of PS-ASO/protein interactions with P54nrb and RNase H1
Timothy A. Vickers et al.
NUCLEIC ACIDS RESEARCH (2019)
Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications
Sebastien Benizri et al.
BIOCONJUGATE CHEMISTRY (2019)
Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways
Maire F. Osborn et al.
NUCLEIC ACIDS RESEARCH (2019)
Diverse lipid conjugates for functional extra-hepatic siRNA delivery in vivo
Annabelle Biscans et al.
NUCLEIC ACIDS RESEARCH (2019)
Integrated Assessment of the Clinical Performance of GalNAc3-Conjugated 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides: I. Human Volunteer Experience
Stanley T. Crooke et al.
NUCLEIC ACID THERAPEUTICS (2019)
Characterization of the interactions of chemically-modified therapeutic nucleic acids with plasma proteins using a fluorescence polarization assay
Hans J. Gaus et al.
NUCLEIC ACIDS RESEARCH (2019)
Structural Determinants for the Interactions of Chemically Modified Nucleic Acids with the Stabilin-2 Clearance Receptor
Hans Gaus et al.
BIOCHEMISTRY (2018)
Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular Vesicles
Reka Agnes Haraszti et al.
MOLECULAR THERAPY (2018)
Acute hepatotoxicity of 2′ fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins
Wen Shen et al.
NUCLEIC ACIDS RESEARCH (2018)
Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides
Shiyu Wang et al.
NUCLEIC ACIDS RESEARCH (2018)
Structure-activity relationships and cellular mechanism of action of small molecules that enhance the delivery of oligonucleotides
Rudolph L. Juliano et al.
NUCLEIC ACIDS RESEARCH (2018)
Paraspeckles: Where Long Noncoding RNA Meets Phase Separation
Archa H. Fox et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
The Effects of 2-O-Methoxyethyl Oligonucleotides on Renal Function in Humans
Stanley T. Crooke et al.
NUCLEIC ACID THERAPEUTICS (2018)
Endosomal Escape of ASOs Internalized by Stabilin Receptors Is Regulated by Rab5C and EEA1 During Endosomal Maturation
Colton M. Miller et al.
NUCLEIC ACID THERAPEUTICS (2018)
Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver
Colton M. Miller et al.
NUCLEIC ACID THERAPEUTICS (2018)
Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Do Not
R. L. Juliano
NUCLEIC ACID THERAPEUTICS (2018)
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
Aaron D. Springer et al.
NUCLEIC ACID THERAPEUTICS (2018)
Improving Small Interfering RNA Delivery In Vivo Through Lipid Conjugation
Maire F. Osborn et al.
NUCLEIC ACID THERAPEUTICS (2018)
Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells
Amy E. Arnold et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathways
Xue-hai Liang et al.
NUCLEIC ACIDS RESEARCH (2018)
Molecular dissection of nuclear paraspeckles: towards understanding the emerging world of the RNP milieu
Shinichi Nakagawa et al.
OPEN BIOLOGY (2018)
Membrane Destabilization Induced by Lipid Species Increases Activity of Phosphorothioate-Antisense Oligonucleotides
Shiyu Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Targeted delivery of antisense oligonucleotides to pancreatic β-cells
C. Ammala et al.
SCIENCE ADVANCES (2018)
Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics
Graham McClorey et al.
BIOMEDICINES (2018)
Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy
Jogender Tushir-Singh
EXPERT OPINION ON BIOLOGICAL THERAPY (2017)
Cellular uptake and trafficking of antisense oligonucleotides
Stanley T. Crooke et al.
NATURE BIOTECHNOLOGY (2017)
Overcoming cellular barriers for RNA therapeutics
Steven F. Dowdy
NATURE BIOTECHNOLOGY (2017)
The impact of base stacking on the conformations and electrostatics of single-stranded DNA
Alex Plumridge et al.
NUCLEIC ACIDS RESEARCH (2017)
Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides
Shiyu Wang et al.
NUCLEIC ACIDS RESEARCH (2017)
Asialoglycoprotein receptor 1 mediates productive uptake of N-acetylgalactosamine-conjugated and unconjugated phosphorothioate antisense oligonucleotides into liver hepatocytes
Michael Tanowitz et al.
NUCLEIC ACIDS RESEARCH (2017)
Characterizing the effect of GalNAc and phosphorothioate backbone on binding of antisense oligonucleotides to the asialoglycoprotein receptor
Karsten Schmidt et al.
NUCLEIC ACIDS RESEARCH (2017)
Nucleic acid binding proteins affect the subcellular distribution of phosphorothioate antisense oligonucleotides
Jeffrey K. Bailey et al.
NUCLEIC ACIDS RESEARCH (2017)
The Effects of 2′-O-Methoxyethyl Containing Antisense Oligonucleotides on Platelets in Human Clinical Trials
Stanley T. Crooke et al.
NUCLEIC ACID THERAPEUTICS (2017)
Electronic Structures of LNA Phosphorothioate Oligonucleotides
Henrik G. Bohr et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
On Characterizing the Interactions between Proteins and Guanine Quadruplex Structures of Nucleic Acids
Ewan K. S. McRae et al.
JOURNAL OF NUCLEIC ACIDS (2017)
Development of antibody-siRNA conjugate targeted to cardiac and skeletal muscles
Tsukasa Sugo et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
Nicholas J. Viney et al.
LANCET (2016)
An improved smaller biotin ligase for BioID proximity labeling
Dae In Kim et al.
MOLECULAR BIOLOGY OF THE CELL (2016)
Integrated Safety Assessment of 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides in NonHuman Primates and Healthy Human Volunteers
Stanley T. Crooke et al.
MOLECULAR THERAPY (2016)
Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity
Xue-Hai Liang et al.
NUCLEIC ACIDS RESEARCH (2016)
Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver
Colton M. Miller et al.
NUCLEIC ACIDS RESEARCH (2016)
Development of a Quantitative BRET Affinity Assay for Nucleic Acid-Protein Interactions
Timothy A. Vickers et al.
PLOS ONE (2016)
Principles and Properties of Stress Granules
David S. W. Protter et al.
TRENDS IN CELL BIOLOGY (2016)
Pharmacokinetic and Pharmacodynamic Investigations of ION-353382, a Model Antisense Oligonucleotide: Using Alpha-2-Macroglobulin and Murinoglobulin Double-Knockout Mice
Colby S. Shemesh et al.
NUCLEIC ACID THERAPEUTICS (2016)
Development of a Method for Profiling Protein Interactions with LNA-Modified Antisense Oligonucleotides Using Protein Microarrays
Satoko Kakiuchi-Kiyota et al.
NUCLEIC ACID THERAPEUTICS (2016)
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Richard S. Geary et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Effect of 2 '-O-[2-[2-(N,N-dimethylamino)ethoxy]ethyl] modification on activity of gapmer antisense oligonucleotides containing 2 ',4 '-constrained 2 '-O-ethyl nucleic acid
Sanjay K. Pandey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells
Daniela Castanotto et al.
NUCLEIC ACIDS RESEARCH (2015)
Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages
Xue-hai Liang et al.
NUCLEIC ACIDS RESEARCH (2015)
The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA
Timothy A. Vickers et al.
NUCLEIC ACIDS RESEARCH (2015)
2′-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF
Wen Shen et al.
NUCLEIC ACIDS RESEARCH (2015)
Stereochemical bias introduced during RNA synthesis modulates the activity of phosphorothioate siRNAs
Hartmut Jahns et al.
NATURE COMMUNICATIONS (2015)
Substitution of tryptophan 89 with tyrosine switches the DNA binding mode of PC4
Jinguang Huang et al.
SCIENTIFIC REPORTS (2015)
Synthesis, biophysical properties and biological activity of second generation antisense oligonucleotides containing chiral phosphorothioate linkages
W. Brad Wan et al.
NUCLEIC ACIDS RESEARCH (2014)
Phosphorothioate oligonucleotides can displace NEAT1 RNA and form nuclear paraspeckle-like structures
Wen Shen et al.
NUCLEIC ACIDS RESEARCH (2014)
Sequence motifs associated with hepatotoxicity of locked nucleic acid-modified antisense oligonucleotides
Andrew D. Burdick et al.
NUCLEIC ACIDS RESEARCH (2014)
TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells
Xue-hai Liang et al.
NUCLEIC ACIDS RESEARCH (2014)
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2014)
Defining the Factors That Contribute to On-Target Specificity of Antisense Oligonucleotides
Walt F. Lima et al.
PLOS ONE (2014)
Antisense Oligonucleotides Capable of Promoting Specific Target mRNA Reduction via Competing RNase H1-Dependent and Independent Mechanisms
Timothy A. Vickers et al.
PLOS ONE (2014)
Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
Fritz Eckstein
NUCLEIC ACID THERAPEUTICS (2014)
Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9
Ekambar R. Kandimalla et al.
NUCLEIC ACIDS RESEARCH (2013)
Oligonucleotide conjugates for therapeutic applications
Johannes Winkler
THERAPEUTIC DELIVERY (2013)
Lipid Conjugated Oligonucleotides: A Useful Strategy for Delivery
Mouna Raouane et al.
BIOCONJUGATE CHEMISTRY (2012)
Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes
Erich Koller et al.
NUCLEIC ACIDS RESEARCH (2011)
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms
Akin Akinc et al.
MOLECULAR THERAPY (2010)
Lipid-based systemic delivery of siRNA
Yu-Cheng Tseng et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Cellular Delivery and Biological Activity of Antisense Oligonucleotides Conjugated to a Targeted Protein Carrier
Hyunmin Kang et al.
BIOCONJUGATE CHEMISTRY (2008)
Structure of human RNase h1 complexed with an RNA/DNA hybrid: Insight into HIV reverse transcription
Marcin Nowotny et al.
MOLECULAR CELL (2007)
P bodies and the control of mRNA translation and degradation
Roy Parker et al.
MOLECULAR CELL (2007)
A global transcription cofactor bound to juxtaposed strands of unwound DNA
S Werten et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Plasma protein binding of an antisense oligonucleotide targeting human ICAM-1 (ISIS 2302)
Tanya A. Watanabe et al.
OLIGONUCLEOTIDES (2006)
Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes
C Matranga et al.
CELL (2005)
P54nrb forms a heterodimer with PSP1 that localizes to paraspeckles in an RNA-dependent manner
AH Fox et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression
C Maris et al.
FEBS JOURNAL (2005)
Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs
HJ Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
RNA interference and chemically modified small interfering RNAs
M Manoharan
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
Structural basis of single-stranded RNA recognition
AC Messias et al.
ACCOUNTS OF CHEMICAL RESEARCH (2004)
Human RNase H1 uses one tryptophan and two lysines to position the enzyme at the 3′-DNA/5′-RNA terminus of the heteroduplex substrate
WF Lima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
PSF and p54nrb/NonO -: multi-functional nuclear proteins
Y Shav-Tal et al.
FEBS LETTERS (2002)
Binding of phosphorothioate oligonucleotides to zwitterionic liposomes
DM Lu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2002)
Investigating the structure of human RNase H1 by site-directed mutagenesis
HJ Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cellular proteins prevent antisense phosphorothioate oligonucleotide (SdT18) to target sense RNA (rA18): Development of a new in vitro assay
I Brukner et al.
BIOCHEMISTRY (2000)
Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation
MK Bijsterbosch et al.
NUCLEIC ACIDS RESEARCH (2000)
Phosphorothioate oligodeoxynucleotides: What is their origin and what is unique about them?
F Eckstein
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2000)
Share Paper
